Kevin M. Friedman
- Oncology top 10%
- Immunology top 10%
- Molecular Biology
- Hematology
- Biomedical Engineering
- Co-authors
- Christopher HorvathTracy E. GarrettHolly M. HortonSamir N. KhleifRasha Abu EidMikayel MkrtichyanJohn EvansRichard A. Morgan
- Topics
- CAR-T cell therapy research (13 papers)Immune Cell Function and Interaction (5 papers)Immunotherapy and Immune Responses (3 papers)
- Cited by
- OncologyImmunologyHematology
- Partner nations
- United StatesAustraliaGermany
In The Last Decade
Kevin M. Friedman
15 papers receiving 522 citations
Peers
Comparison fields: 5 of 51
- Oncology 405
- Immunology 283
- Molecular Biology 193
- Hematology 67
- Biomedical Engineering 57
Countries citing papers authored by Kevin M. Friedman
This map shows the geographic impact of Kevin M. Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin M. Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin M. Friedman more than expected).
Fields of papers citing papers by Kevin M. Friedman
This network shows the impact of papers produced by Kevin M. Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin M. Friedman. The network helps show where Kevin M. Friedman may publish in the future.
Co-authorship network of co-authors of Kevin M. Friedman
This figure shows the co-authorship network connecting the top 25 collaborators of Kevin M. Friedman. A scholar is included among the top collaborators of Kevin M. Friedman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin M. Friedman. Kevin M. Friedman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 3 | |
| 3 | 166 | |
| 4 | 4 | |
| 5 | 4 | |
| 6 | 1 | |
| 7 | 43 | |
| 8 | 4 | |
| 9 | 7 | |
| 10 | 23 | |
| 11 | 126 | |
| 12 | 81 | |
| 13 | 17 | |
| 14 | 2 | |
| 15 | 45 |
About Kevin M. Friedman
Kevin M. Friedman is a scholar working on Oncology, Immunology and Hematology, having authored 15 papers that have together received 530 indexed citations. Recurring topics across this work include CAR-T cell therapy research (13 papers), Immune Cell Function and Interaction (5 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Oncology (405 citations), Immunology (283 citations) and Hematology (67 citations). Kevin M. Friedman has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Christopher Horvath, Tracy E. Garrett, Holly M. Horton, Samir N. Khleif, Rasha Abu Eid, Mikayel Mkrtichyan, John Evans, Richard A. Morgan, Raed Samara and Laurent Ozbun. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.